Aqs Biocair Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 12-12-2024
- Paid Up Capital ₹ 0.50 M
as on 12-12-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2020)
- Profit 72.34%
(FY 2020)
- Ebitda 76.00%
(FY 2020)
- Net Worth -57.44%
(FY 2020)
- Total Assets 5.46%
(FY 2020)
About Aqs Biocair
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Balamurugan Lakshmikanthan, Arunachalam Subbiyan, and Palaniappan Subbaiyan serve as directors at the Company.
- CIN/LLPIN
U24100TN2017FTC118341
- Company No.
118341
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
30 Aug 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aqs Biocair?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arunachalam Subbiyan  | Managing Director | 30-Aug-2017 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balamurugan Lakshmikanthan | Director | 30-Aug-2017 | Current |
Palaniappan Subbaiyan  | Director | 30-Aug-2017 | Current |
Financial Performance of Aqs Biocair.
Aqs Biocair Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 72.34% increase in profit. The company's net worth observed a substantial decline by a decrease of 57.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aqs Biocair?
In 2019, Aqs Biocair had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aerospace Quality Supplier Private LimitedActive 7 years 6 monthsBalamurugan Lakshmikanthan, Arunachalam Subbiyan and 1 more are mutual person
- Transtechno Industrial Services Private LimitedActive 5 years 8 months
Balamurugan Lakshmikanthan and Arunachalam Subbiyan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aqs Biocair?
Unlock and access historical data on people associated with Aqs Biocair, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aqs Biocair, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aqs Biocair's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
